Delivery Order SPE2DB20D1100-SPE2DB25FA6G6
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,154.60 firm fixed-price delivery order is for the supply of 4,561,949,900 units of the drug Dactinomycin 500 MCG Vials, with a performance period through August 28, 2023. This award is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The federal contract award, with ID SPE2DX22D0019|SPE2D825FCJ10, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,452.84 firm fixed-price delivery order contract has an ultimate completion date of January 6, 2025. The award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $12,990.43 firm fixed-price delivery order contract has an ultimate completion date of October 22, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,672.68 firm fixed-price delivery order contract has a period of performance through January 31, 2025. The contract is not designated with a set-aside. It is associated with the company's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award is a delivery order with a firm fixed price of $5,287.68 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is with the Defense Logistics Agency (DLA), an agency within the U.S. Department of Defense, to supply a variety of pharmaceutical products and medical supplies to support military healthcare programs. The contract has an ultimate completion date of July 3, 2025 and is not designated as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $109,867.10 firm fixed-price delivery order contract has an ultimate completion date of July 8, 2025. The award provides for the supply of a range of pharmaceutical products and medical supplies, including medications across therapeutic areas such as diabetes, neurology, pain management, and antibiotics. This...
- This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor and healthcare solutions provider) was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,173.10 firm-fixed-price delivery order has an ultimate completion date of October 30, 2024. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of various pharmaceutical products and medical supplies. The contract is a Delivery Order valued at $10,610.88 and has a firm fixed price pricing structure with a completion date of September 10, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December...
- This federal contract award is for a Delivery Order valued at $18,126.00 with Amerisourcebergen Drug Corp, a major pharmaceutical distributor, as the prime contractor. The contract is with the Defense Logistics Agency (DLA), a component of the Department of Defense, and covers the provision of a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The contract has a firm fixed-price...
- This federal contract award, SPE2DX22D0049|SPE2D825FA4EG, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $7,978.11 firm fixed-price delivery order supports the agency's medical supply chain requirements, providing a range of pharmaceutical products and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract has an ultimate completion date of February 25, 2025....
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FA6G6Delivery Order
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FA6G6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,080.00 firm fixed-price delivery order is for the supply of 4567268132 - DACTINOMYCIN 500 MCG VIALS. The contract has an ultimate completion date of February 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 2/13/25 |